Adial Pharmaceuticals (ADIL) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Adial Pharmaceuticals (ADIL) is Neutral.

The composite score behind that read is -0.01, weighing +0.43 of bullish evidence against -0.50 bearish.

Adial Pharmaceuticals last closed at $3.90, -1.76% on the session.

Against the IVW growth benchmark the position is -2.56% over the forecast window.

The read is built from 15 underlying insights — 4 bullish and 11 bearish.

Agreement across those insights is 73%.

20 graded predictions for ADIL so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Adial Pharmaceuticals in the 99th percentile on return on equity, where 100 is best.

Adial Pharmaceuticals is classified under Health Care / Pharmaceuticals, with a market capitalisation of $10.43M.

StockMap tracks Adial Pharmaceuticals as the 130th largest of the 151 companies it covers in the Pharmaceuticals industry, part of the Health Care sector.

Across that group the current two-week reads are 90 Neutral, 46 Moderate Underperform and 15 Moderate Outperform.

On that composite Adial Pharmaceuticals ranks 57th of 151 in the group, against a group median of -0.08.